PureCycle Technologies Inc
For the period ended Sep 30, 2024. Filed Nov 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 15, 2024
PCT$2.06+23.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023
CONDENSED CONSOLID ATED BALANCE SHEETS
| ASSETS | ||
|---|---|---|
| (Unaudited) | ||
| (in thousands) | September 30, 2024 | December 31, 2023 |
| CURRENT ASSETS | ||
| Cash and cash equivalents | $83,673 | $73,411 |
| Debt securities available for sale | — | 48,226 |
| Restricted cash – current | 241 | 25,692 |
| Inventory | 6,620 | 4,791 |
| Prepaid expenses and other current assets | 10,962 | 10,525 |
| Total current assets | 101,496 | 162,645 |
| Restricted cash – non-current | 9,739 | 203,411 |
| Prepaid expenses and other non-current assets | 4,835 | 4,772 |
| Operating lease right-of-use assets | 27,318 | 29,799 |
| Property, plant and equipment, net | 645,389 | 638,746 |
| TOTAL ASSETS | $788,777 | $1,039,373 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $2,333 | $2,881 |
| Accrued expenses | 29,593 | 35,391 |
| Accrued interest | 5,427 | 8,190 |
| Current portion of warrant liability | 9,051 | — |
| Current portion of long-term debt | 10,839 | 9,148 |
| Current portion of related party bonds payable | 1,040 | — |
| Total current liabilities | 58,283 | 55,610 |
| NON-CURRENT LIABILITIES | ||
| Deferred revenue | 5,000 | 5,000 |
| Long-term debt, less current portion | 255,031 | 467,708 |
| Related party bonds payable | 74,427 | — |
| Related party note payable | — | 39,696 |
| Warrant liability | 104,392 | 22,059 |
| Operating lease right-of-use liabilities | 25,462 | 27,253 |
| Preferred stock liability | 15,270 | — |
| Put option liability | 7,333 | — |
| Other non-current liabilities | 2,163 | 1,811 |
| TOTAL LIABILITIES | $547,361 | $619,137 |
| COMMITMENT AND CONTINGENCIES | — | — |
| STOCKHOLDERS' EQUITY | ||
| Common Stock - $0.001 par value, 450,000 shares authorized; 173,494 and 164,279 shares issued and outstanding as of September 30, 2024 and December 31, 2023 | 173 | 164 |
| Preferred stock - $0.001 par value, 25,000 shares authorized; 50 and no shares issued and outstanding as of September 30, 2024 and December 31, 2023 | — | — |
| Additional paid-in capital | 809,996 | 764,344 |
| Accumulated other comprehensive income (loss) | (55) | (32) |
| Accumulated deficit | (568,698) | (344,240) |
| TOTAL STOCKHOLDERS' EQUITY | 241,416 | 420,236 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $788,777 | $1,039,373 |
CONDENSED CONSOLIDATED STATEM ENTS OF COMPREHENSIVE LOSS
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands except per share data) | ||||
| Costs and expenses | ||||
| Operating costs | $16,965 | $17,053 | $60,379 | $36,037 |
| Research and development | 1,544 | 1,592 | 4,940 | 4,917 |
| Selling, general and administrative | 12,789 | 12,958 | 44,883 | 39,063 |
| Total operating costs and expenses | 31,298 | 31,603 | 110,202 | 80,017 |
| Interest expense | 14,567 | 11,500 | 41,676 | 16,183 |
| Interest income | (414) | (2,867) | (4,530) | (6,377) |
| Change in fair value of warrants | 44,899 | (48,817) | 54,532 | (17,669) |
| Loss on debt extinguishment | — | — | 21,214 | — |
| Other expense | 289 | 51 | 1,364 | 526 |
| Total other expense | 59,341 | (40,133) | 114,256 | (7,337) |
| Loss before income taxes | (90,639) | 8,530 | $(224,458) | $(72,680) |
| Provision for income taxes | — | — | — | — |
| Net Loss | $(90,639) | $8,530 | $(224,458) | $(72,680) |
| Loss per share | ||||
| Basic | $(0.54) | $0.05 | $(1.36) | $(0.44) |
| Diluted | $(0.54) | $0.03 | $(1.36) | $(0.45) |
| Weighted average shares of common stock | ||||
| Basic | 166,513 | 164,018 | 165,224 | 163,783 |
| Diluted | 166,513 | 165,548 | 165,224 | 163,980 |
| Other comprehensive income | ||||
| Cumulative translation adjustment | $(66) | $— | $(41) | $— |
| Unrealized gain on debt securities available for sale | — | (7) | 18 | 634 |
| Total comprehensive loss | $(90,705) | $8,523 | $(224,481) | $(72,046) |
CONDENSED CONSOLIDATED STATE MENTS OF STOCKHOLDERS’ EQUITY
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| (in thousands) | Shares | Amount | Additional paid-in capital | Accumulated other comprehensive (loss) income | Accumulated deficit | Total stockholders' equity |
| Balance, December 31, 2023 | 164,279 | $164 | $764,344 | $(32) | $(344,240) | $420,236 |
| Options exercised | 16 | — | 92 | — | — | 92 |
| Share repurchase | (99) | — | (598) | — | — | (598) |
| Equity-based compensation | 416 | 1 | 2,681 | — | — | 2,682 |
| Unrealized gain on available for sale debt securities | — | — | — | 18 | — | 18 |
| Cumulative translation adjustment | — | — | — | 16 | — | 16 |
| Net loss | — | — | — | — | (85,607) | (85,607) |
| Balance, March 31, 2024 | 164,612 | $165 | $766,519 | $2 | $(429,847) | $336,839 |
| Share repurchase | (14) | — | (97) | — | — | (97) |
| Equity-based compensation | 148 | — | 3,072 | — | — | 3,072 |
| Cumulative translation adjustment | — | — | — | 9 | — | 9 |
| Net loss | — | — | — | — | (48,212) | (48,212) |
| Balance, June 30, 2024 | 164,746 | $165 | $769,494 | $11 | $(478,059) | $291,611 |
| Issuance of common stock | 8,529 | 8 | 38,102 | — | — | 38,110 |
| Share repurchase | (87) | — | (483) | — | — | (483) |
| Equity-based compensation | 306 | — | 2,883 | — | — | 2,883 |
| Cumulative translation adjustment | — | — | — | (66) | — | (66) |
| Net loss | — | — | — | — | (90,639) | (90,639) |
| Balance at September 30, 2024 | 173,494 | $173 | $809,996 | $(55) | $(568,698) | $241,416 |
| Common Stock | |||||||
|---|---|---|---|---|---|---|---|
| (in thousands) · Shares · Amount · Additional paid-in capital · Accumulated other comprehensive (loss) income · Accumulated deficit · Total stockholders' equity | |||||||
| Balance, December 31, 2022 | 163,550 | $164 | $753,885 | $(641) | $(242,525) | $510,883 | |
| Share repurchase | (48) | — | (277) | — | — | (277) | |
| Equity-based compensation | 169 | — | 2,166 | — | — | 2,166 | |
| Unrealized gain on available for sale debt securities | — | — | — | 641 | — | 641 | |
| Net loss | — | — | — | — | (25,842) | (25,842) | |
| Balance, March 31, 2023 | 163,671 | $164 | $755,774 | $— | $(268,367) | $487,571 | |
| Share repurchase | (9) | — | (27) | — | — | (27) | |
| Forfeiture of restricted stock | (1) | — | — | — | — | — | |
| Equity-based compensation | 135 | — | 3,252 | — | — | 3,252 | |
| Unrealized loss on available for sale debt securities | — | ||||||
| Net loss | — | — | — | — | (55,368) | (55,368) | |
| Balance, June 30, 2023 | 163,796 | $164 | $758,999 | $— | $(323,735) | $435,428 | |
| Share repurchase | (78) | — | (818) | — | — | (818) |
|---|---|---|---|---|---|---|
| Equity-based compensation | 341 | — | 3,285 | — | — | 3,285 |
| Unrealized loss on available for sale debt securities | — | — | — | (7) | — | (7) |
| Net income | — | — | — | — | 8,530 | 8,530 |
| Balance, September 30, 2023 | 164,059 | $164 | $761,466 | $(7) | $(315,205) | $446,418 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.